Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2023 - 01 - 09 symbols : Snynf save search
Anti-inflammatory therapeutics market size to increase by USD 39.32 billion; North America to contribute 45% of market growth - Technavio
Published: 2023-01-09 (Crawled : 00:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: -0.52%
H: 1.79%
C: 1.73%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.31%
H: 0.66%
C: 0.23%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 0.58%
H: 0.39%
C: 0.03%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.35%
H: 0.12%
C: -1.6%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.49%
H: 0.0%
C: 0.0%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: 0.68%
H: 0.98%
C: 0.71%
america therapeutics growth market
TFF Pharmaceuticals Announces the Appointment of Zamaneh Mikhak, M.D. as Chief Medical Officer
Published: 2023-01-09 (Crawled : 19:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 1.38%
H: 0.28%
C: 0.28%
TFFP | $3.35 6.86% 6.42% 3.7K
|
Health Technology
|
| O: 2.86%
H: 3.7%
C: 1.85%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.82%
H: 0.0%
C: 0.0%
pharmaceuticals medical
Antibiotics market to grow by 5.11% Y-O-Y from 2022 to 2023: Rising prevalence of infectious diseases will drive growth - Technavio
Published: 2023-01-09 (Crawled : 19:00) - prnewswire.com
ALPMF | $9.17 43.47% 16K
|
Health Technology
|
| O: -1.98%
H: 0.0%
C: 0.0%
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: -0.52%
H: 1.79%
C: 1.73%
ALPMY | $9.47 -1.11% 520K
|
Manufacturing
|
| O: -1.78%
H: 0.14%
C: 0.07%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 0.58%
H: 0.39%
C: 0.03%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.35%
H: 0.12%
C: -1.6%
ABT | News | $107.28 1.91% 0.18% 10M
|
Health Technology
|
| O: 0.31%
H: 1.4%
C: 1.2%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.49%
H: 0.0%
C: 0.0%
antibiotics growth market
Innovent Announces First Participant Dosed in a Phase 3 Clinical Study (DREAMS-1) of Mazdutide (IBI362) in Chinese Patients with Type 2 Diabetes
Published: 2023-01-09 (Crawled : 17:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 1.38%
H: 0.28%
C: 0.28%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.29%
H: 0.27%
C: -3.89%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.82%
H: 0.0%
C: 0.0%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: 0.02%
H: 0.36%
C: -2.56%
ibi362 chinese diabetes study
DiNAQOR Appoints Two Seasoned Executives to Leadership Team
Published: 2023-01-09 (Crawled : 17:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 1.38%
H: 0.28%
C: 0.28%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.82%
H: 0.0%
C: 0.0%
Rheumatoid Arthritis Market is Expected to Showcase Significant Growth in the 7MM at a Minimal CAGR of 1.9% During the Study Period (2019-2032), Predicts DelveInsight
Published: 2023-01-09 (Crawled : 16:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 1.38%
H: 0.28%
C: 0.28%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.29%
H: 0.27%
C: -3.89%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.82%
H: 0.0%
C: 0.0%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: 0.02%
H: 0.36%
C: -2.56%
expected growth study market
CureVac Appoints Alexander Zehnder as CEO From April 1, 2023
Published: 2023-01-09 (Crawled : 14:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 1.38%
H: 0.28%
C: 0.28%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.82%
H: 0.0%
C: 0.0%
CVAC | $2.44 0.0% 790K
|
Health Technology
|
| O: 22.46%
H: 10.13%
C: 2.42%
ceo
ReCode Therapeutics Announces Strategic Collaboration with AskBio to Explore Single Vector Gene-Editing Platform
Published: 2023-01-09 (Crawled : 14:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 1.38%
H: 0.28%
C: 0.28%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.82%
H: 0.0%
C: 0.0%
collaboration therapeutics platform
Nurix Therapeutics Advances Promising Targeted Protein Modulation Pipeline and Outlines 2023 Strategic Priorities
Published: 2023-01-09 (Crawled : 14:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 1.38%
H: 0.28%
C: 0.28%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.82%
H: 0.0%
C: 0.0%
NRIX 3 d | $13.6 -5.82% -6.18% 1M
|
Health Technology
|
| O: 1.82%
H: 0.0%
C: -8.06%
therapeutics
IGM Biosciences Announces Update on IGM-8444 Phase 1 Trial and Future Clinical Development
Published: 2023-01-09 (Crawled : 13:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 1.38%
H: 0.28%
C: 0.28%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.82%
H: 0.0%
C: 0.0%
IGMS | $7.2 -2.83% -2.92% 220K
|
Health Technology
|
| O: 10.09%
H: 1.73%
C: -1.29%
igm-8444 trial update phase 1
Foundational RNA and cLNP expert Antonin (Tony) de Fougerolles joins Etherna as independent board member
Published: 2023-01-09 (Crawled : 12:20) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 1.38%
H: 0.28%
C: 0.28%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.82%
H: 0.0%
C: 0.0%
CureVac ernennt Alexander Zehnder zum Vorstandsvorsitzenden ab 1. April 2023
Published: 2023-01-09 (Crawled : 12:00) - curevac.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: 1.9%
H: 0.0%
C: -1.81%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 1.38%
H: 0.28%
C: 0.28%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 0.11%
H: 0.69%
C: -1.23%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.82%
H: 0.0%
C: 0.0%
CVAC | $2.44 0.0% 790K
|
Health Technology
|
| O: 22.46%
H: 10.13%
C: 2.42%
2022 Corporate Reputation of Pharma Companies Report: Patient Perspective of 520 Cancer Patient Groups During 2021
Published: 2023-01-09 (Crawled : 12:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 1.38%
H: 0.28%
C: 0.28%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.82%
H: 0.0%
C: 0.0%
pharma companies cancer
Immune Checkpoint Inhibitors Market Predicted to Reach USD 155.1 Billion, Globally, by 2031 at 16.1% CAGR: Allied Market Research
Published: 2023-01-09 (Crawled : 10:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: 1.9%
H: 0.0%
C: -1.81%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 1.38%
H: 0.28%
C: 0.28%
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: -0.01%
H: 0.0%
C: 0.0%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 0.11%
H: 0.69%
C: -1.23%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.29%
H: 0.27%
C: -3.89%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.82%
H: 0.0%
C: 0.0%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 0.35%
H: 0.86%
C: -0.21%
research market
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
GBR | $1.42 31.48% 11.27% 990K
|
Energy Minerals
KUKE | $2.88 2.49% 7.64% 360K
|
MPLN | $0.6502 -11.74% 4.51% 2.2M
|
Finance
CXM 4 | $11.34 -0.44% 4.27% 1.7M
|
Information
PVL 4 | $1.47 -0.68% 4.08% 77K
|
Energy Minerals
RNR 4 | $224.74 0.85% 3.52% 310K
|
Finance
PZG | $0.4431 0.48% 2.91% 150K
|
Non-Energy Minerals
DBRG | $17.3 0.06% 1.97% 1.2M
|
Finance and Insurance
RC | $8.62 1.77% 0.81% 1M
|
Finance
SIX | $23.45 -0.55% 0.68% 650K
|
Consumer Services
Your saved searches
Save your searches and get alerts when important news are released.